Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) Rose 2.37% to 13.850 HKD

Newtimespace News, as of 09:40 on May 21, Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) was quoted at HKD 13.850, up 2.37%. The ETF opened at HKD 13.530, with a high of HKD 13.850 and a low of HKD 13.530. The latest Net Asset Value (NAV) per unit is HKD 13.590, with a premium rate of -0.44%. The asset size is approximately HKD 2.11 billion.

Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) tracks the Hang Seng Biotech Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to track the overall performance of the 30 largest biotechnology companies listed in Hong Kong that are eligible for Southbound Stock Connect trading. Its constituents cover industries such as pharmaceuticals, biotechnology, medical equipment and supplies, and pharmaceutical distribution, focusing on core biotech fields like innovative drugs, CXO, and medical devices. It provides investors with a high-purity tool for concentrated investment in leading Hong Kong-listed biotech companies and capturing trends in pharmaceutical innovation.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.